Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Neurology, Movement Disorders
Organization
School of Medicine
>
Clinical Science Departments
>
Neurology
>
Neurology, Movement Disorders
Menu
{hide_children: false, active: true, enabled: true}
Overview
{hide_children: true, active: false, enabled: true}
People
Embed Organization Data
Recent Scholarship
Scholars
8
Publications
331
Featured Publications
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Journal Article
npj Parkinson's Disease
·
December 1, 2024
Full text
Cite
Racial Disparities in Low-Value Care in the Last Year of Life for Medicare Beneficiaries With Neurodegenerative Disease.
Journal Article
Neurol Clin Pract
·
April 2024
Full text
Link to item
Cite
An experimental examination of neurostimulation and cognitive restructuring as potential components for Misophonia interventions.
Journal Article
J Affect Disord
·
April 1, 2024
Full text
Link to item
Cite
Search More
Featured Grants
Significance of Protein Synthesis by the Integrated Stress Response in Neuromodulatory Neurons for Adaptive Behavior and Synaptic Plasticity
Research
·
Awarded by National Institutes of Health ·
2023 - 2028
Basal activation state of the integrated stress response determines dopaminergic neuron survival in Parkinson's disease
Fellowship
·
Awarded by National Institutes of Health ·
2024 - 2027
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson¿s Disease
Clinical Trial
·
Awarded by Biogen, Inc. ·
2022 - 2026
A PHASE 3, MULTICENTER, OPEN-LABEL SAFETY STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF SAGE-718 IN PARTICIPANTS WITH HUNTINGTON'S DISEASE
Clinical Trial
·
Awarded by Sage Therapeutics ·
2023 - 2026
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy
Clinical Trial
·
Awarded by Takeda Development Center Americas, Inc ·
2022 - 2025
Search More